1-1 of 1
Jesus Berdeja
Close
Sort by
Journal Articles

Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma

Clinical Trials & Observations
Benjamin A. Derman, Jeffrey Zonder, Donna Reece, Craig Cole, Jesus Berdeja, Andrew T. Stefka, Ajay Major, Andrew Kin, Kent Griffith, Jagoda Jasielec, Andrzej J. Jakubowiak
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5703–5712.
https://doi.org/10.1182/bloodadvances.2022008866
Published: 2023
Includes: Supplemental data